Krebs Biochemicals announces 34th AGM on Sep 29, 2026, with e-voting from Sep 25-28.
Krebs Biochemicals and Industries Limited will hold its 34th Annual General Meeting on September 29, 2026. E-voting will be available from September 25 to September 28, 2026. The Annual Report for FY2025-26 is available on the company and stock exchange websites.
This is a standard procedural announcement for an AGM and does not have a direct material impact on the company's operations or stock price.
The announcement is a routine corporate communication regarding the upcoming Annual General Meeting and does not contain any new financial information or significant business developments.
Krebs Biochemicals and Industries Limited has published a notice regarding its 34th Annual General Meeting (AGM). The AGM is scheduled to be held on Tuesday, 29th September 2026, at 11:30 a.m. through Video Conferencing / Other Audio Visual Means (VC/OAVM).
The Annual Report for the financial year 2025-26, which includes the notice of the AGM, has been sent in electronic mode to members whose email IDs are registered with the Company or with their Depository Participants. The requirement for sending physical copies has been dispensed with as per MCA and SEBI circulars. The notice and annual report are available on the Company's website (www.krebsbiochem.com) and on the websites of BSE Limited (www.bseindia.com) and The National Stock Exchange of India Ltd. (www.nseindia.com), as well as on the website of KFin Technologies Limited (https://evoting.kfintech.com).
In accordance with the Companies Act, 2013, and SEBI regulations, the company is providing an e-voting facility through KFin Technologies Limited. Remote e-voting will commence on Friday, 25th September 2026, at 09:00 a.m. and will conclude on Monday, 28th September 2026, at 05:00 p.m. The cut-off date for determining the eligibility of members to vote is Wednesday, 23rd September 2026. Members who have acquired shares after the dispatch of the annual report and before the cut-off date can obtain user IDs and passwords by contacting KFintech. Members who have cast their vote via remote e-voting may still attend the AGM but cannot vote again. Members holding shares in physical or dematerialized form as of the cut-off date are eligible to vote.
What to do with a filing like this
Krebs Biochemicals and Industries Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krebs Biochemicals and Industries Limited. Read the original for the full detail.